50 Years of Double Helix
Vanemuise Concert Hall - September 12-13, 2003
-   Overview   -   Speakers   -   Programme   -   Biobusiness workshop   -   Bioethics workshop   -   Exhibition   -   Participants   -   Links  
eesti keeles

Organized by:

estonian genome fundation
estonian biocentre
EC projects GENEMILL and
EL flag

tartu ülikool
british embassy
british council

Official Carrier:
estonian air


  Estonian Genome

  tel. +372 7 420 132
  fax +372 7 440 421
- -
- - -

September 12, 14:40-18.00

connect estonia

Connect Estonia and Estonian Genome Foundation will organize in the framework of Gene Forum 2003 a parallel session on biotech business development and partnership aspects. Different aspect of business development and partnership will be discussed during this session. Session will explain the process of business development for small life science companies and deal-making aspects in the biotech industry. Session will be targeted for small life science company managers, business consultancies, service provides as well as researchers.

Workshop programme:

14:40-15:20 Carl-Johan Sundberg, Karolinska Investment Fund, Sweden

"From Discovery to Sustainable Biotech Business: Karolinska model"

Carl Johan Sundberg, Scientific Investment Manager. M.D., Ph.D., certified physician, Associate Professor of Physiology, Karolinska Institutet. Works with human physiology research at the Department of Physiology and Pharmacology, Karolinska Institutet. Project manager (part-time) at the Center for Medical Innovations, Karolinska Institutet, and course leader for "Science-Based Business Enterprises.". Carl-Johan is a KI's project manager in Stockholm School of Entrepreneurship. Formerly managing director of a medical development company, experience of medical journalism at Svenska Dagbladet and ABC Television, USA. .Board member of Global Genomics AB and Karolinska Education AB.

15:20-15:50 Erki Mölder, CEO, Quattromed Ltd, Estonia

"Estonian Biotech - Challanges for 2004-2006"

15:50-16.30 Coffee/tea break and Discussion

16.30-17:00 Ulrica Sehlstedt, CEO, LightUp Technologies AB, Sweden

"How important is partnership for small growing companies"

LightUp Technologies AB is a company developing new solutions for the in vitro diagnostics (IVD) industry. Our activities are focused on developing and bringing to the market cutting-edge molecular based technologies for medical diagnostic uses. First among these technologies is the LightUp Probe, which can be used to identify and quantify the presence of bacteria or viruses. The technique offers a simpler, more accurate method for real-time PCR and can be used in many medical applications, including gene mapping and disease diagnostics. LightUp Technologies was founded in 1998 and is located in Huddinge, south of Stockholm, Sweden.

17.00-17:40 Michael Byström, patent attorney and Mikael Bergstrand, Head of Biotech Group, Albihns AB, Sweden

"Patent Strategies for Biotech Companies in Europe"

17:40-18:00 Discussion